-
Apr 15, 2021, 11:02 AM
by
Full story
-
Apr 15, 2021, 11:02 AM
by
Full story
-
Apr 15, 2021, 01:00 AM
by
User Not Found
Bio-IT World | NVIDIA has announced the next generation of federated learning: Clara 4.0 with global orchestration of edge clients, and an addition to privacy-preserving homomorphic encryption. David Ruau, VP, head of Global Data Assets and Decision Science at Bayer, outlined Bayer’s work with NVIDIA to incorporate Clara Federated Learning.
Full story
-
Apr 14, 2021, 14:25 PM
by
User Not Found
Bio-IT World | Researchers at the Johns Hopkins Kimmel Cancer Center have a newly developed supervised machine learning algorithm that does the best job yet of connecting tissue-specific cancers to potential disease-driving factors.
Full story
-
Apr 12, 2021, 16:25 PM
by
User Not Found
Bio-IT World | At NVIDIA’s GTC event starting this week, NVIDIA CEO Jensen Huang outlined—among other things—partnerships expanding Clara Discovery, NVIDIA’s computational platform for healthcare.
Full story
-
Apr 9, 2021, 01:00 AM
by
User Not Found
Bio-IT World | Cybersecurity challenges have only escalated during the COVID-19 crisis, particularly in the fields of science and healthcare. The past year has seen a dramatic increase in the number of breaches and ransomware attacks for the enterprise networks of labs and healthcare facilities.
Full story
-
Apr 6, 2021, 15:46 PM
by
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced the launch of LabVantage Analytics, a full-featured, self-service advanced analytics solution that lets users easily explore, analyze, and visualize LIMS, enterprise, and external data to gain actionable business insights. Designed by analytics industry experts, LabVantage Analytics seamlessly integrates with all elements of the LabVantage LIMS platform, providing a single user interface and workflow.
Full story
-
Apr 6, 2021, 15:46 PM
by
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, has appointed Mikael Hagstroem as Chief Executive Officer.
Full story
-
Apr 6, 2021, 15:46 PM
by
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced that the 8.6 edition of its flagship LIMS has been designed and tested to optimum cybersecurity standards.
Full story
-
Apr 6, 2021, 15:46 PM
by
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced it has added validation to a number of its subscription-based LIMS. Adding validation support to a cloud-hosted, Software-as-a-Service (SaaS) LIMS increases confidence for organizations that function in regulated sectors, such as pharmaceuticals, biobanking, and clinical and molecular diagnostics.
Full story
-
Apr 6, 2021, 15:46 PM
by
Full story
-
Apr 6, 2021, 01:00 AM
by
User Not Found
Bio-IT World | Researchers at the University of California (UC), San Diego have proposed that the definition of antibiotic resistance be broadened to include treatment failure among patients on appropriate antibiotic therapy, which still encompasses the “great majority of unsuccessful outcomes in infectious disease.
Full story
-
Apr 5, 2021, 14:45 PM
by
Earlier this month, MedAI announces to have integrated its drug research and development platform for the pharmaceutical industry. The company is specialized in AI-assisted R&D and it now provides a wide range of solutions that covers nearly every stage of early drug development, including developing drug targets, biomarker discovery, chemical drug development, protein/antibody development, prediction of drug, crystal form, ADMET prediction, repurposing existing drugs, drug formulation development.
Full story
-
Apr 5, 2021, 14:45 PM
by
Kiniciti, a Welsh, Carson, Anderson & Stowe (“WCAS”) platform company that invests in non-therapeutic companies supporting Cell and Gene Therapy innovation, announced the formation of an Advisory Board and appointment of two inaugural members: Denis Bedoret, PhD, chief executive officer of Imcyse, and Andrew Knudten, chief operating officer of Jaguar Gene Therapy.
Full story
-
Apr 5, 2021, 14:45 PM
by
Full story
-
Apr 5, 2021, 14:45 PM
by
Bioinformatics methods suffer from a significant loss of accuracy when used on sequencing data from under-represented populations because the genetic information of such populations cannot be captured in the linear reference genome. The inherent bias in the industry’s current reference genome favors the European population. A pan-genome approach can provide significant improvements, but it is still suboptimal. The Seven Bridges GRAF Population Solution is ancestry-aware and, therefore, more accurate than both linear and pan-genome approaches.
Full story
-
Apr 5, 2021, 14:45 PM
by
Qlucore, leading software provider of powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics, announces Qlucore Omics Explorer (QOE) version 3.7, an extensive upgrade adding features in many different areas to strengthen visual analysis support even further.
Full story
-
Apr 5, 2021, 14:45 PM
by
Full story
-
Apr 5, 2021, 14:45 PM
by
Full story
-
Apr 5, 2021, 14:43 PM
by
Full story